Zimmer pulls metal-on-metal Durom acetabular hip implants from Australian market

November 1, 2012 by Arezu Sarvestani

Orthopedic devices giant Zimmer cancels its Durom acetabular hip implant component from the Australian market amid higher revision rates.

Zimmer logo

In another blow to the metal-on-metal hip implant market, orthopedic giant Zimmer Holdings (NYSE:ZMH) canceled its Durom Acetabular Component from the Australian Register of Therapeutic Goods, the regulatory agency announced this week.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.